MCID: VLL006
MIFTS: 42

Villous Adenoma

Categories: Cancer diseases, Gastrointestinal diseases
Data Licensing
For inquiries, contact:

Aliases & Classifications for Villous Adenoma

MalaCards integrated aliases for Villous Adenoma:

Name: Villous Adenoma 11 14
Adenoma, Villous 71
Adenoma Villous 53

Classifications:



External Ids:

Disease Ontology 11 DOID:0050869
UMLS 71 C0206674

Summaries for Villous Adenoma

Disease Ontology: 11 An adenoma that is located in the colon and other places in the gastrointestinal tract and sometimes in other parts of the body.

MalaCards based summary: Villous Adenoma, also known as adenoma, villous, is related to urethral villous adenoma and urinary bladder villous adenoma. An important gene associated with Villous Adenoma is MUC5AC (Mucin 5AC, Oligomeric Mucus/Gel-Forming), and among its related pathways/superpathways are Disease and Homology Directed Repair. The drugs Cianidanol and Epigallocatechin gallate have been mentioned in the context of this disorder. Affiliated tissues include colon, appendix and lymph node, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Reduced mammosphere formation

Related Diseases for Villous Adenoma

Diseases related to Villous Adenoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 514)
# Related Disease Score Top Affiliating Genes
1 urethral villous adenoma 32.6 KRT7 CEACAM5
2 urinary bladder villous adenoma 32.3 MUC6 MUC5AC KRT7 CEACAM5 CDX2
3 glandular cystitis 30.6 TP53 KRT7 CDX2
4 bile duct cysts 30.4 KRT7 KRAS HRAS CEACAM5
5 rectum neuroendocrine neoplasm 30.3 KRT7 CDX2
6 renal pelvis adenocarcinoma 30.3 KRT7 CEACAM5
7 anal canal adenocarcinoma 30.2 MUC5AC KRT7 CDX2
8 hemorrhoid 30.2 KRT7 CEACAM5 APC
9 intestinal obstruction 30.1 KRT7 CEACAM5 CDX2
10 ureteral benign neoplasm 30.1 TP53 KRT7
11 cholecystitis 30.1 TP53 MUC6 MUC5AC
12 bile duct adenoma 30.1 TP53 MUC6 KRT7
13 small cell carcinoma 30.1 TP53 KRT7 CEACAM5
14 bladder urothelial carcinoma 30.0 TP53 KRAS HRAS CTNNB1
15 transitional cell carcinoma 30.0 TP53 MSH2 MLH1 KRT7
16 appendiceal neoplasm 29.9 KRT7 KRAS HRAS GNAS CEACAM5 CDX2
17 adenosquamous carcinoma 29.9 MUC5AC KRT7 KRAS HRAS CEACAM5
18 papillary adenoma 29.8 TP53 KRT7 KRAS HRAS CEACAM5
19 bladder cancer 29.7 TP53 MSH2 MLH1 KRT7 KRAS HRAS
20 cervical adenocarcinoma 29.7 TP53 MUC5AC KRT7 KRAS CEACAM5 CDX2
21 adenocarcinoma in situ 29.7 TP53 MUC6 KRT7 KRAS HRAS CEACAM5
22 gastrointestinal stromal tumor 29.7 TP53 KRAS HRAS CTNNB1 CEACAM5
23 extrahepatic bile duct adenoma 29.6 PMS2 MSH6 MSH2 MLH1
24 bladder adenocarcinoma 29.6 TP53 KRT7 CTNNB1 CEACAM5 CDX2
25 rectum cancer 29.2 TP53 MUTYH MSH6 MSH2 MLH1 MIR29A
26 ampulla of vater adenocarcinoma 29.1 SMAD4 MUC6 MUC5AC KRT7 KRAS HRAS
27 appendix adenocarcinoma 29.1 TP53 SMAD4 MSH6 KRT7 KRAS HRAS
28 cholangiocarcinoma 29.1 TP53 SMAD4 MUC5AC KRT7 KRAS CTNNB1
29 pseudomyxoma peritonei 28.9 TP53 MUC6 MUC5AC KRT7 KRAS GNAS
30 rectal benign neoplasm 28.8 TP53 PMS2 MSH6 MSH2 MLH1 KRT7
31 desmoid tumor 28.8 TP53 PMS2 MUTYH MSH6 MSH2 CTNNB1
32 adenoma 28.7 TP53 SMAD4 PMS2 MUTYH MUC6 MUC5AC
33 barrett esophagus 28.7 TP53 SMAD4 MUC6 MUC5AC KRT7 CTNNB1
34 adenocarcinoma 28.6 TP53 SMAD4 MUC5AC MSH6 MSH2 MLH1
35 juvenile polyposis syndrome 28.6 SMAD4 PMS2 MUTYH MSH6 MSH2 MLH1
36 appendix cancer 28.5 TP53 SMAD4 MUC6 MUC5AC KRT7 KRAS
37 ampulla of vater cancer 28.5 TP53 SMAD4 MUC6 MUC5AC MLH1 KRT7
38 bile duct cancer 28.4 TP53 SMAD4 MUC6 MUC5AC MIR29A KRT7
39 gastric adenocarcinoma 28.4 TP53 SMAD4 MLH1 KRAS HRAS GNAS
40 colon adenocarcinoma 28.3 TP53 SMAD4 MSH6 MLH1 KRAS HRAS
41 signet ring cell adenocarcinoma 28.0 TP53 PMS2 MUC6 MUC5AC MSH6 MSH2
42 familial adenomatous polyposis 28.0 TP53 SMAD4 PMS2 MUTYH MSH6 MSH2
43 lung cancer susceptibility 3 28.0 TP53 SMAD4 MUC5AC MLH1 KRT7 KRAS
44 diffuse gastric cancer 28.0 TP53 SMAD4 PMS2 MUTYH MSH6 MSH2
45 duodenum adenocarcinoma 27.7 SMAD4 PMS2 MUTYH MUC6 MUC5AC MSH6
46 duodenum cancer 27.7 TP53 SMAD4 PMS2 MUTYH MUC6 MUC5AC
47 mucinous adenocarcinoma 27.5 TP53 SMAD4 PMS2 MUC6 MUC5AC MSH6
48 pancreatic cancer 27.4 TP53 SMAD4 MUC6 MUC5AC MSH6 MSH2
49 rectum adenocarcinoma 27.4 TP53 SMAD4 PMS2 MSH6 MSH2 MLH1
50 colorectal adenocarcinoma 27.4 TP53 SMAD4 PMS2 MSH6 MSH2 MLH1

Graphical network of the top 20 diseases related to Villous Adenoma:



Diseases related to Villous Adenoma

Symptoms & Phenotypes for Villous Adenoma

GenomeRNAi Phenotypes related to Villous Adenoma according to GeneCards Suite gene sharing:

25 (show all 21)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-1 9.98 MLH1
2 Increased shRNA abundance (Z-score > 2) GR00366-A-107 9.98 SMAD4
3 Increased shRNA abundance (Z-score > 2) GR00366-A-11 9.98 SMAD4
4 Increased shRNA abundance (Z-score > 2) GR00366-A-124 9.98 MLH1
5 Increased shRNA abundance (Z-score > 2) GR00366-A-133 9.98 APC
6 Increased shRNA abundance (Z-score > 2) GR00366-A-135 9.98 KRT7
7 Increased shRNA abundance (Z-score > 2) GR00366-A-192 9.98 APC KRT7
8 Increased shRNA abundance (Z-score > 2) GR00366-A-195 9.98 MLH1 SMAD4
9 Increased shRNA abundance (Z-score > 2) GR00366-A-200 9.98 MLH1
10 Increased shRNA abundance (Z-score > 2) GR00366-A-202 9.98 APC
11 Increased shRNA abundance (Z-score > 2) GR00366-A-212 9.98 SMAD4
12 Increased shRNA abundance (Z-score > 2) GR00366-A-25 9.98 SMAD4
13 Increased shRNA abundance (Z-score > 2) GR00366-A-43 9.98 SMAD4
14 Increased shRNA abundance (Z-score > 2) GR00366-A-47 9.98 CTNNB1
15 Increased shRNA abundance (Z-score > 2) GR00366-A-68 9.98 KRT7
16 Increased shRNA abundance (Z-score > 2) GR00366-A-72 9.98 KRT7
17 Increased shRNA abundance (Z-score > 2) GR00366-A-74 9.98 KRT7
18 Increased shRNA abundance (Z-score > 2) GR00366-A-78 9.98 MLH1
19 Increased shRNA abundance (Z-score > 2) GR00366-A-91 9.98 KRT7
20 Reduced mammosphere formation GR00396-S 9.17 GNAS HRAS KRAS KRT7 MUC5AC MUTYH
21 Synthetic lethal with vaccinia virus (VACV) infection GR00362-A 8.85 MSH6

MGI Mouse Phenotypes related to Villous Adenoma:

45 (show all 13)
# Description MGI Source Accession Score Top Affiliating Genes
1 neoplasm MP:0002006 10.37 APC CDX2 CEACAM5 CTNNB1 GNAS HRAS
2 homeostasis/metabolism MP:0005376 10.34 APC CDX2 CEACAM5 CTNNB1 GNAS HRAS
3 digestive/alimentary MP:0005381 10.21 APC CDX2 CEACAM5 CTNNB1 GNAS HRAS
4 cellular MP:0005384 10.2 APC CDX2 CEACAM5 CTNNB1 GNAS KRAS
5 endocrine/exocrine gland MP:0005379 10.18 APC CDX2 CEACAM5 CTNNB1 GNAS HRAS
6 normal MP:0002873 10.16 APC CDX2 CTNNB1 GNAS HRAS KRAS
7 renal/urinary system MP:0005367 10.1 APC CTNNB1 GNAS HRAS KRAS KRT7
8 muscle MP:0005369 10.08 APC CEACAM5 CTNNB1 GNAS HRAS KRAS
9 immune system MP:0005387 10.07 APC CEACAM5 CTNNB1 GNAS KRAS MLH1
10 limbs/digits/tail MP:0005371 10 APC CDX2 CTNNB1 GNAS KRAS SMAD4
11 hematopoietic system MP:0005397 9.93 APC CEACAM5 CTNNB1 GNAS KRAS MLH1
12 mortality/aging MP:0010768 9.83 APC CDX2 CEACAM5 CTNNB1 GNAS HRAS
13 integument MP:0010771 9.36 APC CTNNB1 GNAS HRAS KRAS MIR29A

Drugs & Therapeutics for Villous Adenoma

Drugs for Villous Adenoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 6)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cianidanol Approved, Withdrawn Phase 2 154-23-4 9064
2
Epigallocatechin gallate Investigational Phase 2 989-51-5 65064
3
Epigallocatechin Experimental, Investigational Phase 2 970-74-1 72277
4
Epicatechin Investigational Phase 2 490-46-0 58571364 72276
5 Cola Phase 2
6 Tea Phase 2

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Minimizing the Risk of Metachronous Adenomas of the Colorectum With Green Tea Extract -MIRACLE- Completed NCT01360320 Phase 2
2 Outcomes of Endoscopic Resection of Mucosal and Submucosal Lesions in the Duodenum and Ampulla Recruiting NCT02306603
3 Outcomes of Endoscopic Resection in the Upper Gastrointestinal Tract Recruiting NCT02305290
4 Outcomes of Endoscopic Resection of Mucosal and Submucosal Lesions in the Stomach. Recruiting NCT02306707

Search NIH Clinical Center for Villous Adenoma

Genetic Tests for Villous Adenoma

Anatomical Context for Villous Adenoma

Organs/tissues related to Villous Adenoma:

FMA: Colon
MalaCards : Colon, Appendix, Lymph Node, Pancreas, Small Intestine, Prostate, Adrenal Gland

Publications for Villous Adenoma

Articles related to Villous Adenoma:

(show top 50) (show all 1016)
# Title Authors PMID Year
1
Aberrant expression of a human mucin gene (MUC5AC) in rectosigmoid villous adenoma. 53 62
8536891 1996
2
Korean guidelines for postpolypectomy colonoscopic surveillance: 2022 revised edition. 62
36225130 2022
3
[Relationship of diffusion kurtosis imaging parameters with the pathologic type and prognosis of rectal tumors]. 62
36380670 2022
4
Clinicopathological spectrums and prognosis of primary appendiceal adenocarcinoma, goblet cell adenocarcinoma, and low-grade appendiceal mucinous neoplasms. 62
36454563 2022
5
Mucinous adenocarcinoma of the prostatic urethra after brachytherapy for prostatic adenocarcinoma: a case series. 62
35926810 2022
6
Synchronous primary duodenal papillary adenocarcinoma and gallbladder carcinoma: A case report and review of literature. 62
36186218 2022
7
[Korean Guidelines for Postpolypectomy Colonoscopic Surveillance: 2022 Revised Edition]. 62
36156035 2022
8
Ten or More Cumulative Lifetime Adenomas Are Associated with Increased Risk for Advanced Neoplasia and Colorectal Cancer. 62
34089135 2022
9
Primary hepatic neuroendocrine carcinoma with colon adenoma: A case report with literature review. 62
35636210 2022
10
Villous adenoma of the prostatic urethra. 62
35381754 2022
11
Prevalence and predictors of colon polyps in patients with skin tags: A cross sectional study. 62
34008290 2022
12
McKittrick-Wheelock syndrome: rectal villous adenoma as a cause of acute renal failure. 62
35034459 2022
13
Uncommon Association of Mckittrick-Wheelock Syndrome and Clostridioides difficile Infection in Acute Renal Failure. 62
35453832 2022
14
Efficacy and Safety of Exploring Deeper Sections of the Infrapapillary Area of the Duodenum by Using Sedative Esophagogastroduodenoscopy. 62
35935715 2022
15
CASE STUDY: MAJOR DUODENAL PAPILLA CANCER COMPLICATED BY ACUTE PARACANCROTIC NECROTIZING PANCREATITIS. 62
35633340 2022
16
McKittrick-Wheelock Syndrome: A Neoplastic Cause of Electrolyte Imbalance. 62
35402344 2022
17
Clinical outcomes of endoscopic submucosal dissection for colorectal neoplasms: A single-center experience in Southern Taiwan. 62
36206286 2022
18
Influence of early colorectal cancer component on the positive margins after endoscopic resection: a retrospective study. 62
35093004 2022
19
Urachal mucinous cystadenoma: An exceptional entity. 62
34354928 2021
20
Long-term cumulative incidence of metachronous advanced colorectal neoplasia after colonoscopy and a novel risk factor: a cohort study. 62
34402471 2021
21
Factors predicting occurrence and therapeutic choice in malignant colorectal polyps: a study of 13 years of colonoscopic polypectomy. 62
35673811 2021
22
Rare case of advanced rectal cancer with multiple liver and bone metastases presenting with McKittrick-Wheelock syndrome. 62
34584983 2021
23
Ileal Tubulo-Villous Adenoma Causing Small Bowel Obstruction in a Virgin Abdomen. 62
34589331 2021
24
Molecular profiling of appendiceal serrated lesions, polyps and mucinous neoplasms: a single-centre experience. 62
33712927 2021
25
Villous adenoma of bladder with uncommon location in a super-aged patient without gross hematuria. 62
34258525 2021
26
Sarcomatoid urothelial carcinoma arising in the female urethral diverticulum. 62
34058799 2021
27
Telomerase reverse transcriptase (TERT) promoter mutations in primary adenocarcinoma of bladder and urothelial carcinoma with glandular differentiation: pathogenesis and diagnostic implications. 62
33674765 2021
28
Microscopic transduodenal excision of an ampullary adenoma: A case report and review of the literature. 62
34222457 2021
29
Non-conventional dysplasia in inflammatory bowel disease is more frequently associated with advanced neoplasia and aneuploidy than conventional dysplasia. 62
33155325 2021
30
Differential Expression Profiles of Mitogenome Associated MicroRNAs Among Colorectal Adenomatous Polyps. 62
33628862 2021
31
Transanal minimal invasive surgery (TAMIS): safety and feasibility for the resection of benign and malignant lesions of the rectum. 62
34585088 2021
32
Villous adenoma of the renal pelvis: a common entity at an uncommon location. 62
34307234 2021
33
Giant Villous Adenoma: A Rare Case of Colorectal Adenoma that Mimic Colorectal Cancer. 62
33397878 2021
34
Villous Adenoma Arising in the Urethra of a Female with Bladder Augmentation History: A Case Report and Review of the Literature. 62
32779155 2021
35
Villous adenoma of the urethra. 62
33678969 2021
36
[Loop colostomy as a risk factor of postoperative ileus in elective colorectal cancer surgery]. 62
34941210 2021
37
Giant villous adenoma of the sigmoid colon: an unusual cause of homogeneous, segmental bowel wall thickening. 62
33299583 2020
38
Reliability in villous tumors staging between preoperative MRI and histopathological examination. 62
32123949 2020
39
Transanal minimally invasive surgery (TAMIS) for rectal tumor: a case report and literature review. 62
33145320 2020
40
Molecular Genetic Features of Primary Nonurachal Enteric-type Adenocarcinoma, Urachal Adenocarcinoma, Mucinous Adenocarcinoma, and Intestinal Metaplasia/Adenoma: Review of the Literature and Next-generation Sequencing Study. 62
32520749 2020
41
Villous adenoma of the urachus obscuring urachal adenocarcinoma: A case report. 62
32477881 2020
42
Adult duodenal intussusception with horizontal adenoma: A rare case report. 62
32874987 2020
43
Colonoscopy in patients with psoriasis before the initiation of treatment with biological agents. 62
32506694 2020
44
A rare case of huge villous adenoma of the renal pelvis deforming the abdominal wall. 62
32309146 2020
45
Nomograms that predict the survival of patients with adenocarcinoma in villous adenoma of the colorectum: a SEER-based study. 62
32600342 2020
46
Lessons of the month 2: McKittrick-Wheelock syndrome: Case report of a patient declining resection of a large villous adenoma. 62
32414717 2020
47
Endoscopic resection of a prolapsing giant villous adenoma of the supraanal rectum. 62
31447294 2020
48
Evaluation of a Deep Neural Network for Automated Classification of Colorectal Polyps on Histopathologic Slides. 62
32324237 2020
49
Villous Morphology in Urinary Bladder Biopsy: An Approach to Diagnosis. 62
31409167 2020
50
A histopathological rarity: Primary signet ring cell carcinoma arising within a colonic villous adenoma. 62
32031145 2020

Variations for Villous Adenoma

Expression for Villous Adenoma

Search GEO for disease gene expression data for Villous Adenoma.

Pathways for Villous Adenoma

Pathways related to Villous Adenoma according to GeneCards Suite gene sharing:

(show all 40)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.6 TP53 SMAD4 PMS2 MUTYH MUC6 MUC5AC
2
Show member pathways
13.15 TP53 PMS2 MUTYH MSH6 MSH2 MLH1
3
Show member pathways
12.85 TP53 MSH6 MSH2 MLH1 KRAS HRAS
4
Show member pathways
12.77 MIR29A KRAS HRAS CTNNB1 APC
5
Show member pathways
12.69 TP53 KRAS HRAS GNAS CTNNB1
6
Show member pathways
12.68 PMS2 MUTYH MSH6 MSH2 MLH1
7
Show member pathways
12.56 MLH1 MSH2 MSH6 MUTYH PMS2
8
Show member pathways
12.5 TP53 MSH2 KRAS HRAS CTNNB1
9
Show member pathways
12.43 TP53 KRAS HRAS CTNNB1
10
Show member pathways
12.42 SMAD4 GNAS CTNNB1 APC
11 12.41 TP53 MUTYH MSH6 MSH2 MLH1
12 12.38 TP53 GNAS CTNNB1 APC
13
Show member pathways
12.38 TP53 KRAS HRAS CTNNB1
14
Show member pathways
12.37 MUC6 MUC5AC KRAS HRAS
15
Show member pathways
12.37 TP53 SMAD4 KRAS HRAS CTNNB1 APC
16
Show member pathways
12.31 PMS2 MUTYH MSH6 MSH2 MLH1
17
Show member pathways
12.23 TP53 SMAD4 MSH6 MSH2 MLH1 KRAS
18 12.18 SMAD4 CTNNB1 CDX2 APC
19 12.1 CTNNB1 HRAS KRAS SMAD4 TP53
20 12.02 CTNNB1 KRAS MSH2 MSH6 SMAD4 TP53
21 11.98 TP53 PMS2 MSH2 MLH1 APC
22 11.91 KRAS HRAS CTNNB1 APC
23
Show member pathways
11.76 MSH2 MSH6 TP53
24 11.76 CTNNB1 HRAS TP53
25 11.74 TP53 MSH2 MLH1
26 11.74 TP53 SMAD4 KRAS HRAS CTNNB1 APC
27
Show member pathways
11.72 TP53 KRAS HRAS
28 11.67 TP53 SMAD4 KRAS HRAS CTNNB1
29 11.66 APC CTNNB1 SMAD4
30 11.66 APC CTNNB1 HRAS
31
Show member pathways
11.58 KRAS HRAS GNAS
32 11.49 TP53 SMAD4 MSH6 MSH2 MLH1 KRAS
33
Show member pathways
11.36 TP53 MSH2 MLH1
34 11.35 TP53 KRAS HRAS
35 11.31 MSH2 MSH6 TP53
36 11.28 SMAD4 KRAS HRAS
37 11.2 PMS2 MSH6 MSH2 MLH1
38 11 APC CTNNB1 HRAS KRAS SMAD4
39
Show member pathways
10.75 KRAS HRAS
40
Show member pathways
10.2 PMS2 MLH1

GO Terms for Villous Adenoma

Cellular components related to Villous Adenoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 MutLalpha complex GO:0032389 9.46 PMS2 MLH1
2 MutSalpha complex GO:0032301 9.26 MSH6 MSH2
3 mismatch repair complex GO:0032300 9.02 PMS2 MSH2 MLH1

Biological processes related to Villous Adenoma according to GeneCards Suite gene sharing:

(show all 13)
# Name GO ID Score Top Affiliating Genes
1 negative regulation of cell population proliferation GO:0008285 10.2 TP53 SMAD4 MIR29A HRAS CTNNB1 APC
2 intrinsic apoptotic signaling pathway GO:0097193 9.91 TP53 MSH6 HRAS
3 cellular response to DNA damage stimulus GO:0006974 9.91 TP53 PMS2 MUTYH MSH6 MSH2 MLH1
4 determination of adult lifespan GO:0008340 9.88 TP53 MSH6 MSH2
5 isotype switching GO:0045190 9.85 MLH1 MSH2 MSH6
6 positive regulation of helicase activity GO:0051096 9.83 MSH6 MSH2
7 positive regulation of isotype switching to IgA isotypes GO:0048298 9.8 MSH2 MLH1
8 hair follicle placode formation GO:0060789 9.69 GNAS CTNNB1
9 maintenance of DNA repeat elements GO:0043570 9.65 MSH6 MSH2
10 somatic hypermutation of immunoglobulin genes GO:0016446 9.56 PMS2 MSH6 MSH2 MLH1
11 somatic recombination of immunoglobulin gene segments GO:0016447 9.55 MSH6 MSH2 MLH1
12 somatic recombination of immunoglobulin genes involved in immune response GO:0002204 9.5 MSH2 MLH1
13 mismatch repair GO:0006298 9.32 PMS2 MUTYH MSH6 MSH2 MLH1

Molecular functions related to Villous Adenoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 chromatin binding GO:0003682 10.23 TP53 SMAD4 MSH6 MSH2 MLH1 CTNNB1
2 MutSalpha complex binding GO:0032407 9.85 PMS2 MUTYH MLH1
3 oxidized purine DNA binding GO:0032357 9.8 MSH2 MSH6 MUTYH
4 ATP-dependent DNA damage sensor activity GO:0140664 9.76 PMS2 MSH6 MSH2 MLH1
5 single guanine insertion binding GO:0032142 9.73 MSH6 MSH2
6 single thymine insertion binding GO:0032143 9.71 MSH6 MSH2
7 MutLalpha complex binding GO:0032405 9.65 MSH2 MSH6 MUTYH
8 guanine/thymine mispair binding GO:0032137 9.43 MSH6 MSH2 MLH1
9 mismatched DNA binding GO:0030983 9.1 PMS2 MSH6 MSH2 MLH1

Sources for Villous Adenoma

2 CDC
6 CNVD
8 Cosmic
9 dbSNP
10 DGIdb
16 EFO
17 ExPASy
18 FMA
19 GARD
27 GO
28 GTR
29 HMDB
30 HPO
31 ICD10
32 ICD10 via Orphanet
33 ICD11
34 ICD9CM
35 IUPHAR
36 LifeMap
38 LOVD
40 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
52 NINDS
53 Novoseek
55 ODiseA
56 OMIM via Orphanet
57 OMIM® (Updated 08-Dec-2022)
61 PubChem
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....